Health Press Release – Newsletter for January 21, 2011

Oncos Therapeutics Appoints Dr. Jonathan Knowles and Dr. Robert Burns to the Board of Directors

HELSINKI, January 20, 2011 – Oncos Therapeutics, a biotech company developing novel cancer
therapeutics based on its next generation oncolytic viruses, announced today
the appointments of Dr. Jonathan Knowles and Dr. Robert Burns to the Board of
Directors.

"This is one of the most interesting new approaches to cure
cancer. The anti-tumor immune response induced …. Source article  : Oncos Therapeutics Appoints Dr. Jonathan Knowles and Dr. Robert Burns to the Board of Directors.

MarketsandMarkets: Top 10 Drug Delivery Technologies Market to be US$156 Billion by 2015

DALLAS, January 20, 2011 – The 'Top 10 Drug Delivery Technologies Market (2010 – 2015)' analyzes the
drug delivery technologies market by the top 10 drug delivery technologies
and studies the major market drivers, restraints, and opportunities in North
America, Europe, Asia and ROW.

Browse 75 market data tables and in-depth TOC on Top … Read more : MarketsandMarkets: Top 10 Drug Delivery Technologies Market to be US$156 Billion by 2015.

Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance

Cognizant's Next-Generation "Business Process as a Service" Model to Provide Lilly USA Greater Flexibility and Predictability

TEANECK, New Jersey, January 20, 2011 – Cognizant (Nasdaq: CTSH), a leading provider of consulting, technology,
and business process outsourcing (BPO) services, announced that it has been
selected by Eli Lilly and Company, one the world's leading innovation-driven
pharmaceutical companies, to deliver …. Source  : Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance.

European Research Council Selects Elsevier’s SciVerse Scopus Database

Funding Body Will Use Publications and Citations Data to Track Success of Funded Projects

AMSTERDAM, January 20, 2011 – Elsevier's SciVerse Scopus (www.info.sciverse.com/scopus/)
database was selected by the European Research Council (ERC) to assist in the
tracking and awarding of funding opportunities for researchers throughout the
world. The ERC, the European funding body managing the 'Ideas Programme of
the … Read more >>>.

Bupa Care Homes to Host Storytelling Week Events

LONDON, January 20, 2011 – Bupa Care Homes in Yorkshire are preparing to enjoy a number of
storytelling events in support of National Storytelling Week (29 January to 5
February 2011).

This year, Bupa has teamed up with charity The Reader Organisation, which
has been working with care homes (
www.bupa.co.uk/individuals/care-homes) since 2006, promoting the …. Source article  : Bupa Care Homes to Host Storytelling Week Events.

InformexUSA 2011 Projects Record Attendance

Exhibitor and registration numbers reflect growing market confidence
PRINCETON, New Jersey, January 20, 2011 – Informex (www.informex.com), the leading meeting place for buyers
and sellers of high-value chemistry for a broad range of applications, today
announced projections that 2011 will be a record setting year for both
attendee and exhibitor numbers at the brand's flagship event, InformexUSA
(February 7-10, … Read the original article on Gaea Times at : InformexUSA 2011 Projects Record Attendance.

Study Suggests Urine NGAL Biomarker May Help Predict Delayed Graft Function

DELKENHEIM, Germany, January 20, 2011 – A diagnostic test for early detection of acute kidney injury may assist
in predicting delayed graft function (DGF) in kidney transplant patients,
according to a Finnish study published in Kidney International, the journal
of the International Society of Nephrology.

DGF occurs when a transplanted kidney does not function … Read : Study Suggests Urine NGAL Biomarker May Help Predict Delayed Graft Function.

Abbott’s XIENCE PRIME(TM) Receives CE Mark for Treatment of Most Advanced Form of Arterial Disease in the Lower Leg

Positive Results of DESTINY Trial Supported CE Mark for XIENCE PRIME for the Treatment of Critical Limb Ischemia or Severe Claudication (Pain) of the Lower Leg

BRUSSELS, January 20, 2011 – Abbott announced today that it has received CE Mark for its XIENCE
PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of
critical limb ischemia (CLI) …. Original article  : Abbott's XIENCE PRIME(TM) Receives CE Mark for Treatment of Most Advanced Form of Arterial Disease in the Lower Leg.

Disciplinary Committee Suspends Former Southampton Vet

LONDON, January 20, 2011 – The Disciplinary Committee of the Royal College of Veterinary Surgeons
has this week suspended from the RCVS Register a veterinary surgeon formerly
practising in Southampton for failing to make animal welfare his primary
concern.

At a hearing this week [17/18 January] adjourned from September 2010, the
Disciplinary Committee heard charges …. Read the original article  : Disciplinary Committee Suspends Former Southampton Vet.